[Genetic risk factor for the onset and progression of diabetic complication].
Nakajima
Kunihiro
K
Department of Medicine, Metabolism and Endocrinology, School of Medicine, Juntendo University.
Tanaka
Yasushi
Y
D000449:Aldehyde Reductase / Q000235:genetics; D000808:Angiotensinogen / Q000235:genetics; D001057:Apolipoproteins E / Q000235:genetics; D001161:Arteriosclerosis / Q000235:genetics*; D043303:Aryldialkylphosphatase; D004272:DNA, Mitochondrial / Q000235:genetics; D003928:Diabetic Nephropathies / Q000235:genetics*; D003930:Diabetic Retinopathy / Q000235:genetics*; D018450:Disease Progression; D004950:Esterases / Q000235:genetics; D006801:Humans; D042965:Methylenetetrahydrofolate Reductase (NADPH2); D000587:Oxidoreductases Acting on CH-NH Group Donors / Q000235:genetics; D007703:Peptidyl-Dipeptidase A / Q000235:genetics; D017395:Plasminogen Activator Inhibitor 1 / Q000235:genetics; D011110:Polymorphism, Genetic; D000067759:Receptor for Advanced Glycation End Products; D019713:Receptors, CCR5 / Q000235:genetics; D011971:Receptors, Immunologic / Q000235:genetics; D012307:Risk Factors
D001057:Apolipoproteins E; D004272:DNA, Mitochondrial; D017395:Plasminogen Activator Inhibitor 1; D000067759:Receptor for Advanced Glycation End Products; D019713:Receptors, CCR5; D011971:Receptors, Immunologic; D000808:Angiotensinogen; D000449:Aldehyde Reductase; D000587:Oxidoreductases Acting on CH-NH Group Donors; D042965:Methylenetetrahydrofolate Reductase (NADPH2); D004950:Esterases; D043303:Aryldialkylphosphatase; D007703:Peptidyl-Dipeptidase A